KRAS and lung cancer: Our findings are consistent with a recent study by Bartolacci et al., who reported that selective inhibition of FAS favors incorporation of PUFAs into phospholipids via the remodeling pathway in KRAS-mutant lung cancer, thereby lowering the threshold for ferroptosis29.